The PTAB's 70% All-Claims Invalidation Rate Continues to Be a Source of ConcernThe All-Claims Invalidation Rate for patents has escalated dramatically, indicating significant challenges within the U.S. patent system.
Koss Corporation v. Bose CorporationThe case explores how dismissals in one patent litigation can affect the validity and enforceability of patents across concurrent lawsuits.
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study SponsorsThe public disclosure of human clinical trials may potentially lead to the invalidation of pharmaceutical patents, causing concerns for pharmaceutical innovators.